首页> 美国卫生研究院文献>Reviews in Urology >Nephron-sparing Management of Upper Tract Urothelial Carcinoma
【2h】

Nephron-sparing Management of Upper Tract Urothelial Carcinoma

机译:上肾尿道上皮癌的保肾治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Upper tract urothelial carcinoma (UTUC) is a relatively rare tumor, but is characterized by high rates of recurrence, morbidity, and mortality. Choice of treatment modality is generally influenced by lesion size, grade, and focality. Radical nephroureterectomy with bladder cuff excision is the gold-standard management of UTUC, although an organ-sparing approach may be beneficial in selected patients. Conservative endoscopic management of UTUC in appropriate patients has a favorable impact on quality of life and health care costs when compared with patients who progress to dialysis-dependent renal failure. Careful ureteroscopic surveillance following endoscopic management of UTUC is essential.
机译:上尿路尿路上皮癌(UTUC)是一种相对罕见的肿瘤,但其特点是复发率高,发病率高和死亡率高。治疗方式的选择通常受病变大小,等级和病灶影响。根治性膀胱切除术是UTUC的金标准治疗,尽管保留器官的方法可能对某些患者有益。与进展为依赖透析的肾衰竭的患者相比,合适患者的UTUC保守内镜治疗对生活质量和医疗保健成本产生有利影响。内镜治疗UTUC后必须进行仔细的输尿管镜监视。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号